CoChat
Sign Up
Cited by 20HIV/AIDS Research and InterventionsHIV, Drug Use, Sexual RiskHIV/AIDS drug development and treatment

Management of HIV infection in patients with substance use problems

Open access
Nijhawan, Ank, Kim, Soyun, Rich, Josiah D.·2008·Current Infectious Disease Reports
DOI 10.1007/s11908-008-0068-xPMC PMC2936230
Open this paper in CoChat — free account

Abstract

Although highly active antiretroviral therapy (HAART) has greatly reduced overall morbidity and mortality in patients with HIV, patients with substance use issues have been less likely than other patients with HIV to realize these benefits. Social obstacles (eg, lack of housing, minimal social support), and medical comorbidities (eg, mental illness, hepatitis), complicate the management of this group of patients. Not only are drug and alcohol users less likely to access medical care, initiation of HAART may be delayed due to concerns for adherence and the potential development of drug resistance. Ultimately, a multidisciplinary comprehensive approach is needed to both engage and retain this population in care. Through the integration of case management, addiction therapy, and medical treatment of HIV, we may be able to improve outcomes for patients with HIV and addiction.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11908-008-0068-x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • High risk of HIV and AIDS exists in this population.

    “The integration of HIV prevention components in FBT is noteworthy given the high risk of HIV and AIDS in this population (see Nijhawan, Kim, & Rich, 2008).”

    From A controlled evaluation of family behavior therapy in concurrent child neglect and drug abuse. (2014) · cites this paper as Nijhawan, Kim, & Rich, 2008

    The ‘Sexually transmitted infections’ section links drug and alcohol use to sexual risk-taking and notes that STIs can increase HIV transmission. This supports concern about HIV risk, but the paper focuses on people already living with HIV and does not establish a high risk of acquiring HIV or developing AIDS in the FBT population. (LLM, conf=0.78)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 45

  1. [1]Palella FJ Jr Delaney KM Moorman AC Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators N Engl J Med 1998 338 853 860 9516219
  2. [2]Lucas GM Chaisson RE Moore RD Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions Ann Intern Med 1999 131 81 87 10419445
  3. [3]Celentano DD Vlahov D Cohn S Self-reported antiretroviral therapy in injection drug users JAMA 1998 280 544 546 9707145
  4. Celentano DD Lucas G Optimizing treatment outcomes in HIV-infected patients with substance abuse issues Clin Infect Dis 2007 45 Suppl 4 S318 S323 18190306 Up-to-date review of outcomes data in HIV-infected patients with substance use issues and new directions for management.
  5. [5]Knowlton A Arnsten J Eldred L Individual, interpersonal, and structural correlates of effective HAART use among urban active injection drug users J Acquir Immune Defic Syndr 2006 41 486 492 16652058
  6. Bruce RD Altice FL Clinical care of the HIV-infected drug user Infect Dis Clin North Am 2007 21 149 179 ix 17502234 PMC2128697 Outstanding and thorough overview of epidemiology, infectious complications, and management of the overlapping epidemics of HIV and chemical dependence.
  7. [8]Zaller N Gillani FS Rich JD A model of integrated primary care for HIV-positive patients with underlying substance use and mental illness AIDS Care 2007 19 1128 1133 18058396
  8. [9]Bouis S Reif S Whetten K An integrated, multidimensional treatment model for individuals living with HIV, mental illness, and substance abuse Health Soc Work 2007 32 268 278 18038728
  9. [10]Smith-Rohrberg D Mezger J Walton M Impact of enhanced services on virologic outcomes in a directly administered antiretroviral therapy trial for HIV-infected drug users J Acquir Immune Defic Syndr 2006 43 Suppl 1 S48 S53 17133204
  10. [11]Tommasello AC Gillis LM Lawler JT Characteristics of homeless HIV-positive outreach responders in urban US and their success in primary care treatment AIDS Care 2006 18 911 917 17012080
  11. [12]Whetten R Whetten K Pence BW Does distance affect utilization of substance abuse and mental health services in the presence of transportation services? AIDS Care 2006 18 Suppl 1 S27 S34 16938672
  12. [13]Knowlton AR Hoover DR Chung SE Access to medical care and service utilization among injection drug users with HIV/AIDS Drug Alcohol Depend 2001 64 55 62 11470341
  13. [14]Cunningham CO Sohler NL Wong MD Utilization of health care services in hard-to-reach marginalized HIV-infected individuals AIDS Patient Care STDS 2007 21 177 186 17428185
  14. [15]Lum PJ Tulsky JP The medical management of opioid dependence in HIV primary care settings Curr HIV/AIDS Rep 2006 3 195 204 17089480
  15. [16]Khalsa J Vocci F Altice F Buprenorphine and HIV primary care: new opportunities for integrated treatment Clin Infect Dis 2006 43 Suppl 4 S169 S172 17109302
  16. Basu S Smith-Rohrberg D Bruce RD Altice FL Models for integrating buprenorphine therapy into the primary HIV care setting Clin Infect Dis 2006 42 716 721 16447120 Excellent description and evaluation of the different models for integration of buprenorphine into the primary care setting.
  17. [18]Lucas GM Mullen BA Weidle PJ Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups Clin Infect Dis 2006 42 1628 1635 16652321
  18. [19]Macalino GE Hogan JW Mitty JA A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users AIDS 2007 21 1473 1477 17589194
  19. [20]Chander G Lau B Moore RD Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection J Acquir Immune Defic Syndr 2006 43 411 417 17099312 PMC2704473
  20. [21]Hicks PL Mulvey KP Chander G The impact of illicit drug use and substance abuse treatment on adherence to HAART AIDS Care 2007 19 1134 1140 18058397 PMC4126518
  21. [22]Wartenberg AA HIV disease in the intravenous drug user: role of the primary care physician J Gen Intern Med 1991 6 S35 S40 2005476
  22. [23]Vocci FJ Acri J Elkashef A Medication development for addictive disorders: the state of the science Am J Psychiatry 2005 162 1432 1440 16055764
  23. [24]Kuehn BM New therapies for alcohol dependence open options for office-based treatment JAMA 2007 298 2467 2468 18056897
  24. [25]Bigg D Substance use management: a harm reduction-principled approach to assisting the relief of drug-related problems J Psychoactive Drugs 2001 33 33 38 11332999
  25. [27]Strathdee SA Palepu A Cornelisse PG Barriers to use of free antiretroviral therapy in injection drug users JAMA 1998 280 547 549 9707146
  26. [28]Samet JH Libman H Steger KA Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: a cross-sectional study in a municipal hospital clinic Am J Med 1992 92 495 502 1580296
  27. [29]Holzemer WL Corless IB Nokes KM Predictors of self-reported adherence in persons living with HIV disease AIDS Patient Care STDS 1999 13 185 197 10375267
  28. [30]Bouhnik AD Chesney M Carrieri P Nonadherence among HIV-infected injecting drug users: the impact of social instability J Acquir Immune Defic Syndr 2002 31 Suppl 3 S149 S153 12562040
  29. [31]Carrieri MP Villes V Raffi F Self-reported side-effects of anti-retroviral treatment among IDUs: a 7-year longitudinal study (APROCO-COPILOTE COHORT ANRS CO-8) Int J Drug Policy 2007 18 288 295 17689377
  30. [32]Johnson MA Gathe JC Jr Podzamczer D A once-daily lopinavir/ritonavir-based regimen provides noninferior antiviral activity compared with a twice-daily regimen J Acquir Immune Defic Syndr 2006 43 153 160 16951643
  31. [33]Rosenbach KA Allison R Nadler JP Daily dosing of highly active antiretroviral therapy Clin Infect Dis 2002 34 686 692 11823957
  32. [34]McCance-Katz EF Moody DE Morse GD Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine Clin Infect Dis 2006 43 Suppl 4 S224 S234 17109309
  33. [35]McCance-Katz EF Moody DE Smith PF Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavir Clin Infect Dis 2006 43 Suppl 4 S235 S246 17109310
  34. [37]Selwyn PA Feingold AR Hartel D Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS AIDS 1988 2 267 272 3140832
  35. [38]Gordon RJ Lowy FD Bacterial infections in drug users N Engl J Med 2005 353 1945 1954 16267325
  36. [39]Brett MM Hood J Brazier JS Soft tissue infections caused by spore-forming bacteria in injecting drug users in the United Kingdom Epidemiol Infect 2005 133 575 582 16050501 PMC2870283
  37. [40]Wilson LE Thomas DL Astemborski J Prospective study of infective endocarditis among injection drug users J Infect Dis 2002 185 1761 1766 12085322
  38. [41]Alter MJ Epidemiology of viral hepatitis and HIV co-infection J Hepatol 2006 44 S6 S9 16352363
  39. [42]Braitstein P Justice A Bangsberg DR Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort AIDS 2006 20 323 331 16439865
  40. [43]Mast EE Weinbaum CM Fiore AE A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part II: immunization of adults MMWR Recomm Rep 2006 55 1 33 quiz CE1–CE4 17159833
  41. [44]Fleming DT Wasserheit JN From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection Sex Transm Infect 1999 75 3 17 10448335 PMC1758168
  42. [45]Tegger MK Crane HM Tapia KA The effect of mental illness, substance use, and treatment for depression on the initiation of highly active antiretroviral therapy among HIV-infected individuals AIDS Patient Care STDS 2008 22 233 243 18290749
  43. [46]Mijch A Burgess P Judd F Increased health care utilization and increased antiretroviral use in HIV-infected individuals with mental health disorders HIV Med 2006 7 205 212 16630032
  44. [47]Weaver MR Conover CJ Proescholdbell RJ Utilization of mental health and substance abuse care for people living with HIV/AIDS, chronic mental illness, and substance abuse disorders J Acquir Immune Defic Syndr 2008 47 449 458 18197121
  45. [49]Basu S Bruce RD Barry DT Altice FL Pharmacological pain control for human immunodeficiency virus-infected adults with a history of drug dependence J Subst Abuse Treat 2007 32 399 409 17481463 PMC2128698

Cited by

Sorted by citations

Authors
Nijhawan, A., Kim, S., & Rich, J. D.
Affiliations
  • Brown University (US)
  • Miriam Hospital (US)
Corresponding author
Rich, Josiah D.
ORCID
Venue
Current Infectious Disease Reports
Publisher
Springer Science and Business Media LLC
Published
2008-09
Volume
10
Issue
5
Pages
432-438
ISSN
  • 1523-3847 (ISSN-L)
  • 1534-3146
DOI
10.1007/s11908-008-0068-x
PMC
PMC2936230
OpenAlex
W2024028804
Cited by
20
References
1
Citations by year
2024: 2 · 2023: 2 · 2019: 2 · 2018: 1 · 2016: 1 · 2014: 1 · 2013: 2 · 2012: 1
FWCI
1.72
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Current Infectious Disease Reports (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Institute on Drug Abuse (P30DA013868, R01DA018641, T32DA013911)
  • National Institute of Allergy and Infectious Diseases (P30AI042853)
Topics
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
  • Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Keywords
HIV infection, substance use disorders, highly active antiretroviral therapy, medication adherence, drug resistance, health care access, social support, housing instability, psychiatric comorbidity, hepatitis, case management, addiction treatment, multidisciplinary care, retention in care

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review